Literature DB >> 2991306

Proliferation of a human embryonal carcinoma-derived cell line in serum-free medium: inter-relationship between growth factor requirements and membrane receptor expression.

W Engström, A R Rees, J K Heath.   

Abstract

Substantial multiplication in vitro of cloned cells from a human embryonal carcinoma cell line, Tera 2, has been obtained in a basal medium (DMEM/Ham's F12,50:50, v/v) supplemented with 10 micrograms low density lipoprotein/ml, 100 micrograms high density lipoprotein/ml, 100 ng multiplication stimulating activity/ml, 100 ng insulin/ml and 1 microgram transferrin/ml. The growth rate appears to be similar to that obtained in 10% serum. Furthermore, studies on the expression of cell surface receptors revealed that cloned Tera 2 cells express high-affinity receptors for IGF-II but not for insulin. The cells also express receptors for Epidermal Growth Factor (EGF) even though the addition of EGF does not stimulate their proliferation in serum-free medium. These results suggest that the expression of specific growth factor receptors is not an absolute determinant of hormone responsiveness.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991306     DOI: 10.1242/jcs.73.1.361

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  3 in total

1.  Growth requirements, growth factor responsiveness, and growth factor secretion of three human embryonal carcinoma cell lines.

Authors:  W Verbeek; C Bokemeyer; H Falk; H J Schmoll
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

Review 2.  Epigenetic regulation of the Igf2/H19 gene cluster.

Authors:  M Nordin; D Bergman; M Halje; W Engström; A Ward
Journal:  Cell Prolif       Date:  2014-04-16       Impact factor: 6.831

3.  Disproportionate growth in mice with Igf-2 transgenes.

Authors:  A Ward; P Bates; R Fisher; L Richardson; C F Graham
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.